BloodQ
About:
BloodQ develops an analytical platform designed for cancer drug treatment.
Website: https://www.bloodq.com/
Top Investors: Genoa Ventures
Description:
BloodQ develops an analytical platform designed for cancer drug treatment. Its platform captures disease molecular signals in circulating DNA to improve sensitivity, specificity, and timing in diagnostic and disease management, thereby providing patients personalized cancer treatment.
Total Funding Amount:
$4.5M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Orinda, California, United States
Founded Date:
Founders:
Diana Abdueva
Number of Employees:
1-10
Last Funding Date:
2021-07-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai